Univariable | Multivariableb | |||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Patient’s age (index) [per year] | 1.06 (1.01; 1.11) | <0.01 | 0.98 (0.92;1.04) | 0.56 |
Patient’s sex [male vs. female] | 1.10 (0.44; 2.72) | 0.84 | – | – |
Length of hospital stay [log(d)] | 1.58 (1.15; 2.18) | <0.01 | 1.25 (0.83; 1.89) | 0.29 |
Therapy (max.) [vs. no intervention)] | 0.10 | – | – | |
PCI/stent vs. conservative | ||||
CABG vs. conservative | 0.49 (0.21; 1.12) | |||
1.07 (0.39; 2.96) | ||||
AMI during hospital stay | 1.49 (0.76; 2.94) | 0.24 | – | – |
Index hospital stay as primary CHD event [yes vs. no] | 0.32 (0.14; 0.75) | <0.01 | 0.38 (0.14; 1.00) | 0.05 |
History of CHFc | 1.12 (0.56; 2.21) | 0.76 | – | – |
Cardiovascular risk factors | ||||
Diabetesd (index) | 2.57 (1.30; 5.07) | <0.01 | 1.85 (0.77; 4.44) | 0.17 |
Hypertensiond (index) | 2.12 (0.63; 7.09) | 0.22 | – | – |
Hyperlipidemiad (index) | 2.21 (0.95; 5.17) | 0.07 | – | – |
Smoking (index)d | 0.35 (0.10; 1.16) | 0.08 | – | – |
Obesitye (index) | 2.23 (1.11; 4.48) | 0.02 | 1.34 (0.58; 3.11) | 0.49 |
Kidney function | ||||
eGFR at discharge [per ml/min/1.73m2] | 0.93 (0.91; 0.95) | <0.001 | 0.92 (0.89; 0.94) | <0.001 |
AKI-stages [vs.no AKI]f | <0.001 | <0.001 | ||
Stage 1 [vs. no AKI] | 1.51 (0.59; 3.85) | 0.38 (0.12; 1.22) | ||
Stage 2/3 [vs. no AKI] | 54.7 (10.8; 277.7) | 92.7 (10.1; 847.9) |